SUMOylation of Rb enhances its binding with CDK2 and phosphorylation at early G1 phase

References

• Massague J. G1 cell-cycle control and cancer. Nature 2004; 432:298-306; PMID:15549091; http://dx.doi.org/10.1038/nature03094
   PubMed Web of Science ®Google Scholar
• Bertoli C, Skotheim JM, de Bruin RA. Control of cell cycle transcription during G1 and S phases. Nat Rev Mol Cell Biol 2013; 14:518-28; PMID:23877564; http://dx.doi.org/10.1038/nrm3629
   PubMed Web of Science ®Google Scholar
• Weinberg RA. The retinoblastoma protein and cell cycle control. Cell 1995; 81:323-30; PMID:7736585; http://dx.doi.org/10.1016/0092-8674(95)90385-2
   PubMed Web of Science ®Google Scholar
• Burkhart DL, Sage J. Cellular mechanisms of tumour suppression by the retinoblastoma gene. Nat Rev Cancer 2008; 8:671-82; PMID:18650841; http://dx.doi.org/10.1038/nrc2399
   PubMed Web of Science ®Google Scholar
• Dyson N. The regulation of E2F by pRB-family proteins. Gen Dev 1998; 12:2245-62; PMID:9694791; http://dx.doi.org/10.1101/gad.12.15.2245
   PubMed Web of Science ®Google Scholar
• Ezhevsky SA, Ho A, Becker-Hapak M, Davis PK, Dowdy SF. Differential regulation of retinoblastoma tumor suppressor protein by G(1) cyclin-dependent kinase complexes in vivo. Mol Cellular Biol 2001; 21:4773-84; PMID:11416152; http://dx.doi.org/10.1128/MCB.21.14.4773-4784.2001
   PubMed Web of Science ®Google Scholar
• Giacinti C, Giordano A. RB and cell cycle progression. Oncogene 2006; 25:5220-7; PMID:16936740; http://dx.doi.org/10.1038/sj.onc.1209615
   PubMed Web of Science ®Google Scholar
• Ezhevsky SA, Nagahara H, Vocero-Akbani AM, Gius DR, Wei MC, Dowdy SF. Hypo-phosphorylation of the retinoblastoma protein (pRb) by cyclin D:Cdk4/6 complexes results in active pRb. Proc Natl Acad Sci U S A 1997; 94:10699-704; PMID:9380698; http://dx.doi.org/10.1073/pnas.94.20.10699
   PubMed Web of Science ®Google Scholar
• Zarkowska T, Mittnacht S. Differential phosphorylation of the retinoblastoma protein by G1/S cyclin-dependent kinases. J Biol Chem 1997; 272:12738-46; PMID:9139732; http://dx.doi.org/10.1074/jbc.272.19.12738
   PubMed Web of Science ®Google Scholar
• Stevens C, La Thangue NB. E2F and cell cycle control: a double-edged sword. Archives of biochemistry and biophysics 2003; 412:157-69; PMID:12667479; http://dx.doi.org/10.1016/S0003-9861(03)00054-7
   PubMed Web of Science ®Google Scholar
• Harbour JW, Luo RX, Dei Santi A, Postigo AA, Dean DC. Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1. Cell 1999; 98:859-69; PMID:10499802; http://dx.doi.org/10.1016/S0092-8674(00)81519-6
   PubMed Web of Science ®Google Scholar
• Harbour JW, Dean DC. The Rb/E2F pathway: expanding roles and emerging paradigms. Gen Dev 2000; 14:2393-409; PMID:11018009; http://dx.doi.org/10.1101/gad.813200
   PubMed Web of Science ®Google Scholar
• Gareau JR, Lima CD. The SUMO pathway: emerging mechanisms that shape specificity, conjugation and recognition. Nat Rev Mol Cell Biol 2010; 11:861-71; PMID:21102611; http://dx.doi.org/10.1038/nrm3011
   PubMed Web of Science ®Google Scholar
• Yao Q, Li H, Liu BQ, Huang XY, Guo L. SUMOylation-regulated protein phosphorylation, evidence from quantitative phosphoproteomics analyses. J Biol Chem 2011; 286:27342-9; PMID:21685386; http://dx.doi.org/10.1074/jbc.M111.220848
   PubMed Web of Science ®Google Scholar
• Geiss-Friedlander R, Melchior F. Concepts in sumoylation: a decade on. Nat Rev Mol Cell Biol 2007; 8:947-56; PMID:18000527; http://dx.doi.org/10.1038/nrm2293
   PubMed Web of Science ®Google Scholar
• Hay RT. SUMO: a history of modification. Mol Cell 2005; 18:1-12; PMID:15808504; http://dx.doi.org/10.1016/j.molcel.2005.03.012
   PubMed Web of Science ®Google Scholar
• Hickey CM, Wilson NR, Hochstrasser M. Function and regulation of SUMO proteases. Nat Rev Mol Cell Biol 2012; 13:755-66; PMID:23175280; http://dx.doi.org/10.1038/nrm3478
   PubMed Web of Science ®Google Scholar
• Ledl A, Schmidt D, Muller S. Viral oncoproteins E1A and E7 and cellular LxCxE proteins repress SUMO modification of the retinoblastoma tumor suppressor. Oncogene 2005; 24:3810-8; PMID:15806172; http://dx.doi.org/10.1038/sj.onc.1208539
   PubMed Web of Science ®Google Scholar
• Li T, Santockyte R, Shen RF, Tekle E, Wang G, Yang DC, Chock PB. Expression of SUMO-2/3 induced senescence through p53- and pRB-mediated pathways. J Biol Chem 2006; 281:36221-7; PMID:17012228; http://dx.doi.org/10.1074/jbc.M608236200
   PubMed Web of Science ®Google Scholar
• Muller S, Berger M, Lehembre F, Seeler JS, Haupt Y, Dejean A. c-Jun and p53 activity is modulated by SUMO-1 modification. J Biol Chem 2000; 275:13321-9; PMID:10788439; http://dx.doi.org/10.1074/jbc.275.18.13321
   PubMed Web of Science ®Google Scholar
• Tan JA, Song J, Chen Y, Durrin LK. Phosphorylation-dependent interaction of SATB1 and PIAS1 directs SUMO-regulated caspase cleavage of SATB1. Mol Cellular Biol 2010; 30:2823-36; PMID:20351170; http://dx.doi.org/10.1128/MCB.01603-09
   PubMed Web of Science ®Google Scholar
• Gresko E, Ritterhoff S, Sevilla-Perez J, Roscic A, Frobius K, Kotevic I, Vichalkovski A, Hess D, Hemmings BA, Schmitz ML. PML tumor suppressor is regulated by HIPK2-mediated phosphorylation in response to DNA damage. Oncogene 2009; 28:698-708; PMID:19015637; http://dx.doi.org/10.1038/onc.2008.420
   PubMed Web of Science ®Google Scholar
• Gupta P, Ho PC, Huq MM, Ha SG, Park SW, Khan AA, Tsai NP, Wei LN. Retinoic acid-stimulated sequential phosphorylation, PML recruitment, and SUMOylation of nuclear receptor TR2 to suppress Oct4 expression. Proc Natl Acad Sci U S A 2008; 105:11424-9; PMID:18682553; http://dx.doi.org/10.1073/pnas.0710561105
   PubMed Web of Science ®Google Scholar
• Mittnacht S. Control of pRB phosphorylation. Curr Opin Genet Dev 1998; 8:21-7; PMID:9529601; http://dx.doi.org/10.1016/S0959-437X(98)80057-9
   PubMed Web of Science ®Google Scholar
• Jakobs A, Koehnke J, Himstedt F, Funk M, Korn B, Gaestel M, Niedenthal R. Ubc9 fusion-directed SUMOylation (UFDS): a method to analyze function of protein SUMOylation. Nat Methods 2007; 4:245-50; PMID:17277783; http://dx.doi.org/10.1038/nmeth1006
   PubMed Web of Science ®Google Scholar
• Hamdane M, Bretteville A, Sambo AV, Schindowski K, Begard S, Delacourte A, Bertrand P, Buee L. p25/Cdk5-mediated retinoblastoma phosphorylation is an early event in neuronal cell death. J Cell Sci 2005; 118:1291-8; PMID:15741232; http://dx.doi.org/10.1242/jcs.01724
   PubMed Web of Science ®Google Scholar
• Simone C, Bagella L, Bellan C, Giordano A. Physical interaction between pRb and cdk9/cyclinT2 complex. Oncogene 2002; 21:4158-65; PMID:12037672; http://dx.doi.org/10.1038/sj.onc.1205511
   PubMed Web of Science ®Google Scholar
• Kerscher O. SUMO junction-what's your function? New insights through SUMO-interacting motifs. EMBO reports 2007; 8:550-5; PMID:17545995; http://dx.doi.org/10.1038/sj.embor.7400980
   PubMed Web of Science ®Google Scholar
• Song J, Durrin LK, Wilkinson TA, Krontiris TG, Chen Y. Identification of a SUMO-binding motif that recognizes SUMO-modified proteins. Proc Natl Acad Sci U S A 2004; 101:14373-8; PMID:15388847; http://dx.doi.org/10.1073/pnas.0403498101
   PubMed Web of Science ®Google Scholar
• Zhao Q, Xie Y, Zheng Y, Jiang S, Liu W, Mu W, Liu Z, Zhao Y, Xue Y, Ren J. GPS-SUMO: a tool for the prediction of sumoylation sites and SUMO-interaction motifs. Nucleic Acids Res 2014; 42:W325-30; PMID:24880689; http://dx.doi.org/10.1093/nar/gku383
   PubMed Web of Science ®Google Scholar
• Cobrinik D, Francis RO, Abramson DH, Lee TC. Rb induces a proliferative arrest and curtails Brn-2 expression in retinoblastoma cells. Mol Cancer 2006; 5:72; PMID:17163992; http://dx.doi.org/10.1186/1476-4598-5-72
   PubMed Web of Science ®Google Scholar
• Schlabach MR, Luo J, Solimini NL, Hu G, Xu Q, Li MZ, Zhao Z, Smogorzewska A, Sowa ME, Ang XL, et al. Cancer proliferation gene discovery through functional genomics. Science 2008; 319:620-4; PMID:18239126; http://dx.doi.org/10.1126/science.1149200
   PubMed Web of Science ®Google Scholar
• Chen LZ, Li XY, Huang H, Xing W, Guo W, He J, Sun ZY, Luo AX, Liang HP, Hu J, et al. SUMO-2 promotes mRNA translation by enhancing interaction between eIF4E and eIF4G. PloS one 2014; 9:e100457; PMID:24971752; http://dx.doi.org/10.1371/journal.pone.0100457
   PubMedGoogle Scholar
• He X, Riceberg J, Pulukuri SM, Grossman S, Shinde V, Shah P, Brownell JE, Dick L, Newcomb J, Bence N. Characterization of the loss of SUMO pathway function on cancer cells and tumor proliferation. PloS one 2015; 10:e0123882; PMID:25860128; http://dx.doi.org/10.1371/journal.pone.0123882
   PubMed Web of Science ®Google Scholar
• Bellail AC, Olson JJ, Hao C. SUMO1 modification stabilizes CDK6 protein and drives the cell cycle and glioblastoma progression. Nat Commun 2014; 5:4234; PMID:24953629; http://dx.doi.org/10.1038/ncomms5234
   PubMed Web of Science ®Google Scholar
• Bischof O, Schwamborn K, Martin N, Werner A, Sustmann C, Grosschedl R, Dejean A. The E3 SUMO ligase PIASy is a regulator of cellular senescence and apoptosis. Mol cell 2006; 22:783-94; PMID:16793547; http://dx.doi.org/10.1016/j.molcel.2006.05.016
   PubMed Web of Science ®Google Scholar
• Ni HJ, Chang YN, Kao PH, Chai SP, Hsieh YH, Wang DH, Fong JC. Depletion of SUMO ligase hMMS21 impairs G1 to S transition in MCF-7 breast cancer cells. Biochimica et biophysica acta 2012; 1820:1893-900; PMID:22906975; http://dx.doi.org/10.1016/j.bbagen.2012.08.002
   PubMed Web of Science ®Google Scholar
• Nie M, Xie Y, Loo JA, Courey AJ. Genetic and proteomic evidence for roles of Drosophila SUMO in cell cycle control, Ras signaling, and early pattern formation. PloS one 2009; 4:e5905; PMID:19529778; http://dx.doi.org/10.1371/journal.pone.0005905
   PubMed Web of Science ®Google Scholar
• Macdonald JI, Dick FA. Posttranslational modifications of the retinoblastoma tumor suppressor protein as determinants of function. Genes & cancer 2012; 3:619-33; PMID:23634251; http://dx.doi.org/10.1177/1947601912473305
   PubMedGoogle Scholar
• De Luca A, MacLachlan TK, Bagella L, Dean C, Howard CM, Claudio PP, Baldi A, Khalili K, Giordano A. A unique domain of pRb2/p130 acts as an inhibitor of Cdk2 kinase activity. J Biol Chem 1997; 272:20971-4; PMID:9261093; http://dx.doi.org/10.1074/jbc.272.34.20971
   PubMed Web of Science ®Google Scholar
• Zhang HS, Gavin M, Dahiya A, Postigo AA, Ma D, Luo RX, Harbour JW, Dean DC. Exit from G1 and S phase of the cell cycle is regulated by repressor complexes containing HDAC-Rb-hSWI/SNF and Rb-hSWI/SNF. Cell 2000; 101:79-89; PMID:10778858; http://dx.doi.org/10.1016/S0092-8674(00)80625-X
   PubMed Web of Science ®Google Scholar
• Dick FA, Rubin SM. Molecular mechanisms underlying RB protein function. Nat Rev Mol Cell Biol 2013; 14:297-306; PMID:23594950; http://dx.doi.org/10.1038/nrm3567
   PubMed Web of Science ®Google Scholar
• Uchida C, Miwa S, Kitagawa K, Hattori T, Isobe T, Otani S, Oda T, Sugimura H, Kamijo T, Ookawa K, et al. Enhanced Mdm2 activity inhibits pRB function via ubiquitin-dependent degradation. EMBO J 2005; 24:160-9; PMID:15577944; http://dx.doi.org/10.1038/sj.emboj.7600486
   PubMed Web of Science ®Google Scholar
• Chan HM, Krstic-Demonacos M, Smith L, Demonacos C, La Thangue NB. Acetylation control of the retinoblastoma tumour-suppressor protein. Nat Cell Biol 2001; 3:667-74; PMID:11433299; http://dx.doi.org/10.1038/35083062
   PubMed Web of Science ®Google Scholar
• Markham D, Munro S, Soloway J, O'Connor DP, La Thangue NB. DNA-damage-responsive acetylation of pRb regulates binding to E2F-1. EMBO reports 2006; 7:192-8; PMID:16374512; http://dx.doi.org/10.1038/sj.embor.7400591
   PubMed Web of Science ®Google Scholar
• Nguyen DX, Baglia LA, Huang SM, Baker CM, McCance DJ. Acetylation regulates the differentiation-specific functions of the retinoblastoma protein. EMBO J 2004; 23:1609-18; PMID:15044952; http://dx.doi.org/10.1038/sj.emboj.7600176
   PubMed Web of Science ®Google Scholar
• Carr SM, Munro S, Kessler B, Oppermann U, La Thangue NB. Interplay between lysine methylation and Cdk phosphorylation in growth control by the retinoblastoma protein. EMBO J 2011; 30:317-27; PMID:21119616; http://dx.doi.org/10.1038/emboj.2010.311
   PubMed Web of Science ®Google Scholar
• Dong M, Pang X, Xu Y, Wen F, Zhang Y. Ubiquitin-conjugating enzyme 9 promotes epithelial ovarian cancer cell proliferation in vitro. Int J Mol Sci 2013; 14:11061-71; PMID:23708104; http://dx.doi.org/10.3390/ijms140611061
   PubMed Web of Science ®Google Scholar
• Li F, Li X, Kou L, Li Y, Meng F, Ma F. SUMO-conjugating enzyme UBC9 promotes proliferation and migration of fibroblast-like synoviocytes in rheumatoid arthritis. Inflammation 2014; 37:1134-41; PMID:24531852; http://dx.doi.org/10.1007/s10753-014-9837-x
   PubMed Web of Science ®Google Scholar
• Zhao Z, Tan X, Zhao A, Zhu L, Yin B, Yuan J, Qiang B, Peng X. microRNA-214-mediated UBC9 expression in glioma. BMB reports 2012; 45:641-6; PMID:23187003; http://dx.doi.org/10.5483/BMBRep.2012.45.11.097
   PubMed Web of Science ®Google Scholar
• Zhang GJ, Safran M, Wei W, Sorensen E, Lassota P, Zhelev N, Neuberg DS, Shapiro G, Kaelin WG, Jr. Bioluminescent imaging of Cdk2 inhibition in vivo. Nat Med 2004; 10:643-8; PMID:15122251; http://dx.doi.org/10.1038/nm1047
   PubMed Web of Science ®Google Scholar
• Pabla N, Bhatt K, Dong Z. Checkpoint kinase 1 (Chk1)-short is a splice variant and endogenous inhibitor of Chk1 that regulates cell cycle and DNA damage checkpoints. Proc Natl Acad Sci U S A 2012; 109:197-202; PMID:22184239; http://dx.doi.org/10.1073/pnas.110-4767109
   PubMed Web of Science ®Google Scholar
• Singhmar P, Kumar A. Angelman syndrome protein UBE3A interacts with primary microcephaly protein ASPM, localizes to centrosomes and regulates chromosome segregation. PloS one 2011; 6:e20397; PMID:21633703; http://dx.doi.org/10.1371/journal.pone.0020397
   PubMedGoogle Scholar